Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin-nicotinamide induced type 2 diabetic rats

Journal of Applied Biomedicine

Volumn 5, Issue 1, 2007, Pages 31-38

  Murugan, Pidaran ^a   Pari, Leelavinothan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Blood glucose; Curcumin; Diabetes; Fatty acids; Insulin; Tetrahydrocurcumin

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; CURCUMIN; FATTY ACID; GLUCOSE; INSULIN; LINOLENIC ACID; NICOTINAMIDE; OLEIC ACID; PALMITIC ACID; STEARIC ACID; STREPTOZOCIN; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID BRAIN LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTECTION; RAT; STREPTOZOCIN DIABETES;

CURCUMA LONGA; RATTUS;

EID: 33847753474     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2007.005     Document Type: Article

References (43)

1. Aggarwal B, Kumar A, Bharti A: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23:363-398, 2003.
2. Anusuya S, Menon VP: Protection of pancreatic β-cell by the potential antioxidant bis-O-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. J. Pharm. Pharm. Sci. 6:327-333, 2003.
3. Arun N, Nalini N: Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum. Nutr. 57:41-51, 2002.
4. Babu P, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 166:169-175, 1997.
5. Babu P, Srinivasan K: Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol. Cell. Biochem. 181:87-96, 1998.
6. Bassirat M, Khalil Z: Endothelin and free radicals modulate microvascular responses in streptozotocin diabetic rats. Microvasc. Res. 59:88-98, 2000.
7. Baynes YW, Thorpe R: Role of oxidative stress in diabetic complications. Diabetes 48:1-9, 1999.
8. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP: Antidiabetic and antihyperlipidemic effect of neem seed kernal powder on alloxan diabetes. Indian J. Pharmacol. 59:8-13, 1997.
9. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
10. Cameron NE, Cottter MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45:137-146, 1997.
11. Demaison L, Sergiel JP, Moreau D, Grynberg A: Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochodrial oxidative metabolism before and after myocardial ischemia. Biochim. Biophys. Acta 1227:53-59, 1994.
12. Duncan BD: Multiple ranges tests for correlated and heteroscedastic means. Biometrics 13:359-364, 1957.
13. Faas FH, Dang AQ, Norman J, Carter WJ: Red blood cell and plasma fatty acid composition in diabetes mellitus. Metab. Clin. Exp. 37:711-713, 1988.
14. Farva D, Goji LA, Joseph PK, Augusti KT: Effects of garlic oil on streptozotocin-diabetic rats maintained on normal and high fat diets. Indian J. Biochem. Biophys. 23:24-27, 1986.
15. Folsom AR, Ma J, Mc Govern PG, Eckfeldt H: Relation between phospholipids, saturated fatty acids and hyperinsulinemia. Metab. Clin. Exp. 45:223-228, 1996.
16. Halim Eshrat M, Hussain A: Hypoglycemic, hypolipidemic and antioxidant properties of combination of curcumin from Curcuma longa, Linn. and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes. Indian Clin. Biochem. 17: 33-43, 2002.
17. Holder GM, Plummer JL, Ryan AJ: The metabolism and excretion of curcumin (1,7-Bis (4-hydroxy-3-methoxyphenyl)-1,6-hepadiene-3,5-dione) in rat. Xenobiotica 8:761-768, 1978.
18. Ireson CR: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11:105-111, 2002.
19. Khopde SM, Priyadarisini KI, Guha SN, Satav JG, Venkatesan P, Rao MN: Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: Possible mechanism by pulse radiolysis. Biosci. Biotechnol. Biochem. 64:503-509, 2000.
20. King H, Aubert R, Herman WH: Global burden of diabetes 1995-2025. Diabetes Care 21: 414-143, 1998.
21. Lin JK, Lin-Shiau SY: Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. Repub. China B 25:59-66, 2001.
22. Mahesh T, Balasubashini M, Menon V: Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J. Med. Food 8:251-255, 2005.
23. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G: Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229, 1998.
24. Morrison WR, Smith LM: Preparations of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J. Lipid Res. 5:600-607, 1964.
25. Naito M, Wu X, Normura H, Kodama M, Kato Y, Osaswa T: The protective effect of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J. Atheroscler. Thromb. 9:243-250, 2002.
26. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K, Kitahara M: Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 53:959-963, 2005.
27. Okada K, Wangpoengtrakul C, Tanaka T, Toyokuni S, Uchida K, Osawa T: Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J. Nutr. 31:2090-2095, 2001.
28. Pari L, Murugan P: Protective role of tetrahydrocurcumin against erythromycin estolate induced hepatotoxicity. Pharmacol. Res. 49:481-486, 2004.
29. Pari L, Murugan P: Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J. Basic Clin. Physiol. Pharmacol. 16:257-274, 2005.
30. Pelikanova T, Kohout M, Valek J, Base J, Stefka Z: Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulin-dependent) diabetic men. Metabolism 40: 175-180, 1991.
31. Pushparaj P, Tan CH, Tan BKH: Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin diabetic rats. J. Ethnopharmacol. 72: 69-76, 2000.
32. Ravi P, Dai S, Tam KC: Synthesis and self-assembly of [60]fullerene containing sulfobetaine polymer in aqueous solution. J. Phys. Chem. B. Condens. Matter. Mater. Surf. Interfaces Biophys. 8:22791-22798, 2005.
33. Robertson RP: Chronic oxidative stress: a central mechanism for glucose toxicity in pancreatic islet beta cell in diabetes. J. Biol. Chem. 279: 42351-42354, 2004.
34. Sajithlal G, Chithra P, Chandrakasan G: Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem. Pharmacol. 56:1607-1614, 1998.
35. Seigneur M, Freyburger G, Gin H, Claverie M, Lardeau D, Lacape G: Serum fatty acid profiles in type I and II diabetes; metabolic alteration of fatty acids of the main serumlipids. Diabetes Res. Clin. Pract. 23:169-177, 1994.
36. Sidhu G, Mani H, Gaddipati J, Singh A, Seth P, Banaudha K, Patnaik G, Maheshwari R: Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen. 7:362-374, 1999.
37. Stubbs CD, Smith AD: The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim. Biophys. Acta 779:89-137, 1984.
38. Sugiyama Y, Kawakishi S, Osawa T: Involvement of the β-diketone moiety in the antioxidant mechanism of tetrahydrocurcuminoids. Biochem. Pharmacol. 52:519-525, 1996.
39. Suryanarayana P, Saraswat M, Mrudula T, Krishna P, Krishnaswamy K, Reddy G: Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest. Ophthalmol. Vis. Sci. 46:2092-2099, 2005.
40. Tilvis RS, Helve E, Miettinen TA: Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 diabetes. Diabetologia 29:690-694, 1986.
41. Vessby B: Dietary fat and insulin actions in humans. Br. J. Nutr. 83:91-96, 2000
42. Warier PK: Eugenia jambolana Linn. In Warier PK, Nambiar VPK, Ramankutty C. (eds): Indian Medicinal Plants, Orient Longman, Madras 1995, pp. 45-51.
43. + regulates DNA binding of transcription factors to control gene expression related to neuronal apoptosis. Neuroreport 17:1199-1204, 2006.